Ultralow Dose of Naloxone as an Adjuvant to Intrathecal Morphine Infusion Improves Perceived Quality of Sleep but Fails to Alter Persistent Pain: A Randomized, Double-blind, Controlled Study.

Authors:
Block L; Lundborg C; Bjersing J; Dahm P; Hansson E and 1 more

Journal:
Clin J Pain

Publication Year: 2015

DOI:
10.1097/AJP.0000000000000200

PMCID:
PMC4894772

PMID:
25629634

Journal Information

Full Title: Clin J Pain

Abbreviation: Clin J Pain

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Psychophysiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Supported by grants from the University of Gothenburg, Gothenburg Medical Society, Sahlgrenska University Hospital, Lena and Per Sjöbergs Research Fund, and the Health & Medical Care Committee of the Regional Executive Board, Region Västra Götaland, Gothenburg, Sweden. Naloxone, morphine, and other equipment were provided by institutional grants. This study was also supported by Edit Jacobbsons Foundation. Drs C.L. and P.D. declare that they have received payment for educational lectures about pain from Mundipharma AB, Gothenburg, Sweden. The remaining authors declare no conflict of interest."

Evidence found in paper:

"Supported by grants from the University of Gothenburg, Gothenburg Medical Society, Sahlgrenska University Hospital, Lena and Per Sjöbergs Research Fund, and the Health & Medical Care Committee of the Regional Executive Board, Region Västra Götaland, Gothenburg, Sweden. Naloxone, morphine, and other equipment were provided by institutional grants. This study was also supported by Edit Jacobbsons Foundation. Drs C.L. and P.D. declare that they have received payment for educational lectures about pain from Mundipharma AB, Gothenburg, Sweden. The remaining authors declare no conflict of interest."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025